ArticleClinical cancer research : an official journal of the American Association for Cancer Research2013

Concomitant BRAF and PI3K/mTOR blockade is required for effective treatment of BRAF(V600E) colorectal cancer.

Erin M Coffee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.